Compare CABA & JACK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CABA | JACK |
|---|---|---|
| Founded | 2017 | 1951 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 339.1M | 326.6M |
| IPO Year | 2019 | 1994 |
| Metric | CABA | JACK |
|---|---|---|
| Price | $1.42 | $12.21 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 16 |
| Target Price | $13.25 | ★ $19.83 |
| AVG Volume (30 Days) | ★ 5.3M | 478.4K |
| Earning Date | 11-09-2026 | 11-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.26 | N/A |
| EPS | N/A | ★ 1.44 |
| Revenue | N/A | ★ $1,465,314,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.94 |
| P/E Ratio | ★ N/A | $8.79 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.51 | $8.92 |
| 52 Week High | $4.23 | $23.86 |
| Indicator | CABA | JACK |
|---|---|---|
| Relative Strength Index (RSI) | 20.85 | 39.80 |
| Support Level | N/A | $11.92 |
| Resistance Level | $2.14 | $14.02 |
| Average True Range (ATR) | 0.14 | 0.61 |
| MACD | -0.03 | 0.07 |
| Stochastic Oscillator | 4.74 | 29.91 |
Cabaletta Bio Inc is a late clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for autoimmune diseases. Its proprietary Cabaletta Approach to B cell Ablation (CABA) platform includes the CARTA approach, which uses chimeric antigen receptor T cells to eliminate B cells and potentially reset the immune system. The company develops cellular therapies including CAR T and CAAR T product candidates. Its candidate, rese-cel (resecabtagene autoleucel), a CD19-CAR T cell therapy, is being evaluated in Phase 1/2 trials for autoimmune diseases such as systemic lupus erythematosus, myositis, systemic sclerosis, generalized myasthenia gravis, and pemphigus vulgaris.
Jack In The Box Inc operates quick-service restaurants and fast-casual restaurants across various states in the United States of America. Its core business includes the Jack in the Box hamburger chain, known for a broad menu that features hamburgers, tacos, sandwiches, salads, and breakfast items. The company also operates the Del Taco brand, which offers a variety of both Mexican and American favorites such as burritos and fries. These foods are available with the option of customization as per customer requirements. The company also offers catering and delivery services to its customers. Jack in the Box and Del Taco restaurant brands are the two reportable operating segments, of which, Jack in the Box generates maximum revenue for the company.